These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 1693689

  • 1. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
    Schell DL, Drugan A, Brindley BA, Zador IE, Johnson MP, Schwartz DB, Evans MI.
    J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ, Gabert HA, Diket AL, St Amant M, Miller JM.
    J Matern Fetal Med; 1998 May; 7(6):304-7. PubMed ID: 9848697
    [Abstract] [Full Text] [Related]

  • 8. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
    Cusick W, Rodis JF, Vintzileos AM, Albini SM, McMahon M, Campbell WA.
    J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
    [Abstract] [Full Text] [Related]

  • 9. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein.
    Warner AA, Pettenati MJ, Burton BK.
    Obstet Gynecol; 1990 Jan; 75(1):64-6. PubMed ID: 1688649
    [Abstract] [Full Text] [Related]

  • 10. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU, Damm P, Tabor A, Pedersen JF, Mølsted-Pedersen L.
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [Abstract] [Full Text] [Related]

  • 11. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
    Silver RM, Draper ML, Byrne JL, Ashwood EA, Lyon JL, Branch DW.
    Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation].
    Hayashi M, Kohzu H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1211-8. PubMed ID: 1385554
    [Abstract] [Full Text] [Related]

  • 18. Risks associated with an elevated amniotic fluid alpha-fetoprotein level.
    Crandall BF, Matsumoto M.
    Am J Med Genet; 1991 Apr 01; 39(1):64-7. PubMed ID: 1714237
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
    Wenstrom KD, Owen J, Davis RO, Brumfield CG.
    Obstet Gynecol; 1996 Feb 01; 87(2):213-6. PubMed ID: 8559526
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.